Literature DB >> 3001505

Interaction of 9-(1,3-dihydroxy-2-propoxymethyl)guanine with cytosol and mitochondrial deoxyguanosine kinases: possible role in anti-cytomegalovirus activity.

D F Smee.   

Abstract

The acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) is a potent inhibitor of human cytomegalovirus in vitro and in vivo. In order to investigate the phosphorylation of DHPG to the monophosphate and identify the enzyme responsible, attempts were made to isolate DHPG kinase from calf thymus and from human cytomegalovirus-infected lung cells. From calf thymus, a mitochondrial deoxyguanosine kinase was partially purified which co-migrated with DHPG phosphorylating activity on DEAE-cellulose, and had the same mobility by electrophoresis. DHPG triphosphate and DHPG kinase were elevated in cytomegalovirus-infected cells, but not enough enzyme activity was recovered to identify the kinase. However, DHPG was found to inhibit a cytosol deoxyguanosine kinase induced in these infected cells. The role of mitochondrial and cytosol deoxyguanosine kinases is discussed relative to the anti-cytomegalovirus activity of DHPG.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001505     DOI: 10.1007/bf00225929

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  18 in total

1.  Deoxyguanosine kinase. Distinct molecular forms in mitochondria and cytosol.

Authors:  W R Gower; M C Carr; D H Ives
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

2.  Thymidine kinase from blast cells of myelocytic leukemia.

Authors:  Y C Cheng
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Deoxycytidine kinase. II. Purification and general properties of the calf thymus enzyme.

Authors:  J P Durham; D H Ives
Journal:  J Biol Chem       Date:  1970-05-10       Impact factor: 5.157

4.  Rat cytomegalovirus induces cellular purine and pyrimidine nucleoside kinases in rat embryo fibroblasts and TK- rat-2 cells. Correlations with the antiviral activity of Acyclovir.

Authors:  H Meijer; C A Bruggeman; P H Dormans; C P van Boven
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication.

Authors:  M J Tocci; T J Livelli; H C Perry; C S Crumpacker; A K Field
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

6.  New affinity adsorbents containing deoxycytidine, deoxyadenosine, or deoxyguanosine and their interactions with deoxynucleoside-metabolizing enzymes.

Authors:  S Ikeda; I Park; P Gardner; D H Ives
Journal:  Biochemistry       Date:  1984-04-24       Impact factor: 3.162

7.  Metabolism of acyclovir in virus-infected and uninfected cells.

Authors:  P A Furman; P de Miranda; M H St Clair; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

8.  Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.

Authors:  D F Smee; R Boehme; M Chernow; B P Binko; T R Matthews
Journal:  Biochem Pharmacol       Date:  1985-04-01       Impact factor: 5.858

9.  Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.

Authors:  E C Mar; Y C Cheng; E S Huang
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

Authors:  D F Smee; J C Martin; J P Verheyden; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

View more
  7 in total

1.  Antiviral guanosine analogs as substrates for deoxyguanosine kinase: implications for chemotherapy.

Authors:  A Herrström Sjöberg; L Wang; S Eriksson
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.

Authors:  S C Stanat; J E Reardon; A Erice; M C Jordan; W L Drew; K K Biron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase.

Authors:  L L Bennett; P W Allan; G Arnett; Y F Shealy; D S Shewach; W S Mason; I Fourel; W B Parker
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate.

Authors:  K K Biron; J A Fyfe; S C Stanat; L K Leslie; J B Sorrell; C U Lambe; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir.

Authors:  J S Cannon; F Hamzeh; S Moore; J Nicholas; R F Ambinder
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 6.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 7.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.